NANOBIOTIX
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.
NANOBIOTIX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2003-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.nanobiotix.com
Total Employee:
101+
Status:
Active
Contact:
+33140260755
Total Funding:
323.51 M USD
Technology used in webpage:
IPv6 Google Maps Person Schema WordPress 6.0 Gravatar Profiles Apple Whitelist Reddit Akamai Hosted WP Fastest Cache EU Cookie Law
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Nanobiotix
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Nanobiotix
Bpifrance
Bpifrance investment in Grant - Nanobiotix
Bpifrance
Bpifrance investment in Series E - Nanobiotix
Amorçage Rhône Alpes
Amorçage Rhône Alpes investment in Series C - Nanobiotix
Crédit Mutuel Innovation
Crédit Mutuel Innovation investment in Series C - Nanobiotix
Matignon Technologies
Matignon Technologies investment in Series C - Nanobiotix
Karista
Karista investment in Series C - Nanobiotix
Seventure Partners
Seventure Partners investment in Series C - Nanobiotix
Apicap
Apicap investment in Series C - Nanobiotix
Official Site Inspections
http://www.nanobiotix.com Semrush global rank: 2.68 M Semrush visits lastest month: 6.23 K
- Host name: nanobiotix.tempurl.host
- IP address: 95.179.157.236
- Location: Amsterdam Netherlands
- Latitude: 52.3534
- Longitude: 4.9087
- Timezone: Europe/Amsterdam
- Postal: 1091
More informations about "Nanobiotix"
Building new cancer therapies atom by atom | Nanobiotix
Nanobiotix is a late-stage clinical biotechnology company that is pioneering the discovery, development, manufacture, and commercialization of physics-based nanotherapeutics. We …See details»
Patient resources and clinical trials | Nanobiotix
At Nanobiotix, we are committed to applying the power of physics to help people live longer and be in better health. Our lead candidate NBTXR3 is a nanoparticle-based therapy that works by enhancing the effects of radiotherapy on cancer …See details»
Nanobiotix - Wikipedia
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. See details»
Nanobiotix - Crunchbase Company Profile & Funding
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles.See details»
Organization | Nanobiotix - Purdue University
Nanobiotix Report issue For profit Phase 3 Founded: Paris France (2003)See details»
Nanobiotix - MassBio
May 29, 2020 · Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing …See details»
NANOBIOTIX Provides Business Update and Reports Half Year …
Nanobiotix is the owner of more than 25 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) …See details»
Nanobiotix Announces Key Development Milestones for 2021 …
Jan 8, 2021 · About NANOBIOTIX: www.nanobiotix.com Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly …See details»
Nanomedicine pioneers - The story behind Nanobiotix …
Learn how Nanobiotix uses physics to push the frontiers of nanomedicine to expand therapeutic possibilities for patients around the world.See details»
NANOBIOTIX Announces Two Key Supervisory Board Additions …
Sep 4, 2024 · Nanobiotix is the owner of more than 25 umbrella patents associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and …See details»
NANOBIOTIX Announces Launch of Global Follow-On Offering …
PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage …See details»
Nanobiotix - Press release - October 20, 2021 - American Society …
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported …See details»
NANOBIOTIX Provides Business Update and Reports Financial …
Sep 8, 2021 · NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand …See details»
Nanobiotix to Provide Operational Update and Report Full Year …
Nanobiotix is the owner of more than 30 umbrella patents associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and …See details»
Challenging the limits of radiation oncology | Nanobiotix
Discover how Nanobiotix potential first-in-class radioenhancer can treat a range of solid tumors by increasing the radiation absorbed by tumor cells.See details»
NANOBIOTIX Announces Two Key Supervisory Board Additions …
Sep 4, 2024 · Anat Naschitz, proven life science investor and entrepreneur; co-founder of OrbiMed Israel PARIS and CAMBRIDGE, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- …See details»
Search Results for: - Nanobiotix
ABOUT US Nanobiotix is a late-stage clinical biotechnology company that is pioneering the discovery, development, manufacture, and commercialization of physics-based …See details»
NANOBIOTIX Announces Two Key Supervisory Board Additions …
Sep 4, 2024 · Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of …See details»
NANOBIOTIX Announces the Availability of a Prospectus in …
Nov 6, 2023 · Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext since 2012 and on the Nasdaq Global Select Market in New York City since …See details»
Nanobiotix - Funding, Financials, Valuation & Investors - Crunchbase
Nanobiotix is a nanomedicine company developing novel therapeutics for the local treatment of cancer.See details»